Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews...
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • Allergy (Apr 2019)
    • Biology of familial cancer predisposition syndromes (Feb 2019)
    • Mitochondrial dysfunction in disease (Aug 2018)
    • Lipid mediators of disease (Jul 2018)
    • Cellular senescence in human disease (Apr 2018)
    • View all review series...
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Scientific Show Stoppers
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • About
  • Editors
  • Consulting Editors
  • For authors
  • Current issue
  • Past issues
  • By specialty
  • Subscribe
  • Alerts
  • Advertise
  • Contact
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • Brief Reports
  • Technical Advances
  • Commentaries
  • Editorials
  • Hindsight
  • Review series
  • Reviews
  • The Attending Physician
  • First Author Perspectives
  • Scientific Show Stoppers
  • Top read articles
  • Concise Communication
Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver
Kazuaki Miyake, … , Hiroshi Sakaue, Masato Kasuga
Kazuaki Miyake, … , Hiroshi Sakaue, Masato Kasuga
Published November 15, 2002
Citation Information: J Clin Invest. 2002;110(10):1483-1491. https://doi.org/10.1172/JCI15880.
View: Text | PDF
Categories: Article Metabolism

Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver

  • Text
  • PDF
Abstract

Research Article

Authors

Kazuaki Miyake, Wataru Ogawa, Michihiro Matsumoto, Takehiro Nakamura, Hiroshi Sakaue, Masato Kasuga

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
Effects of Δp85 expression in the liver on insulin tolerance and pyruvat...
Effects of Δp85 expression in the liver on insulin tolerance and pyruvate challenge. (a) DNPI3K and LacZ mice were injected intraperitoneally with insulin, and blood glucose concentration was measured at the indicated times thereafter. Data are expressed as a percentage of the initial glucose concentration and are means ± SEM of values obtained from six mice. (b) DNPI3K and LacZ mice were deprived of food for 16 hours, orally administered with 3-MPA (or not), and, after 30 minutes, injected intraperitoneally with pyruvate. Blood glucose concentration was measured at the indicated times thereafter. Data are means ± SEM of values obtained from four mice. *P < 0.05 versus the corresponding value for LacZ mice.
Follow JCI:
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts